3,4-dihydroxyphenylacetic acid has been researched along with Aging in 164 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Haloperidol treatment (2 hours) accelerated striatal DA turnover similarly in all age groups, by about 100%." | 5.26 | Aging and haloperidol-induced dopamine turnover in the nigro-striatal pathway of C57BL/6J mice. ( Finch, CE; Osterburg, HH; Severson, JA, 1981) |
| "Children whose mothers used cocaine during pregnancy appear to have an increased incidence of certain neurobehavioral deficits." | 3.71 | Prenatal cocaine exposure increases mesoprefrontal dopamine neuron responsivity to mild stress. ( Elsworth, JD; Morrow, BA; Roth, RH, 2001) |
| "The aging of the cochlear dopaminergic system has been analyzed by quantifying the levels of dopamine (DA) and its metabolites (3,4-dihydroxyphenylacetic acid, DOPAC, and homovanillic acid, HVA) in adult rats aged 3, 12 or 24 months." | 3.71 | Effects of aging on cochlear monoamine turnover. ( Dávila, D; Gil-Loyzaga, P; Muñoz, E; Vicente-Torres, MA, 2002) |
| "Taurine is present in high concentration in the mammalian brain and is known to decline with aging." | 3.70 | An age-related decline in striatal taurine is correlated with a loss of dopaminergic markers. ( Cullen, MJ; Dawson, R; Gollub, M; Liu, S; Pelleymounter, MA, 1999) |
| " In addition, the exposure to new environmental condition elevated blood corticosterone levels and enhanced behavioral activities to a greater extent in the Dex group than in controls at 7 wk of life, suggesting that elevated glucocorticoid levels during the pregnancy mimicked prenatal mild stress, producing developmental alterations in brain monoamine metabolism, endocrine response, and behavior in adult offspring." | 3.69 | Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring. ( Kamei, K; Kitera, K; Mikuni, M; Muneoka, K; Ogawa, T; Takahashi, K; Takigawa, M, 1997) |
| " The results indicate that aging did not significantly alter the levels of norepinephrine (NE), dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in frontal (FCX), parietal (PCX) and occipital cortices (OCX)." | 3.68 | Effect of aging and diet restriction on monoamines and amino acids in cerebral cortex of Fischer-344 rats. ( Friedman, E; Yeung, JM, 1991) |
| "The long-term effect of the parkinsonism-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central monoaminergic neurons in young (2-3 months) and aging (12 months) C57BL/6 mice has been studied using neurochemical and immunocytochemical techniques." | 3.68 | Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis. ( Date, I; Felten, DL; Felten, SY, 1990) |
| " Neither cortical NE nor its metabolite methoxyhydroxyphenylglycol sulphate (MHPG-SO4) were significantly changed by aging." | 3.67 | Effect of aging on monoamines and their metabolites in the rat brain. ( Carfagna, N; Moretti, A; Trunzo, F, 1987) |
| "Levodopa (l-DOPA, l-3,4-dihydroxyphenylalanine) is the most effective drug in the symptomatic treatment of Parkinson's disease (PD), but chronic use initiates a maladaptive process leading to l-DOPA-induced dyskinesia (LID)." | 1.46 | Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia. ( Andersen, AD; Binzer, M; Blaabjerg, M; Gramsbergen, JBP; Kamal, A; Kjaer, TW; Stenager, E; Thagesen, H, 2017) |
| "Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder of mature and older individuals." | 1.36 | Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. ( Charlton, CG; King, J; Mackey, V; Muthian, G, 2010) |
| " Although increasing the dosage of d-METH (20 to 80 mg/kg) did increase the GFAP response (100% over control), it was still well below that usually exhibited at the usual neurotoxic dosage (300-400% over control) in fully mature mice." | 1.31 | Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. ( Ali, SF; Miller, DB; O'Callaghan, JP, 2000) |
| " A treatment history of high AMPH dosage was associated with a marked sensitization of the exploratory behavior in adults, whereas it induced a quite opposite profile in periadolescents." | 1.31 | Striatal dopamine sensitization to D-amphetamine in periadolescent but not in adult rats. ( Laviola, G; Pascucci, T; Pieretti, S, 2001) |
| "The Fragile X syndrome, a common form of mental retardation in humans, is caused by silencing the fragile X mental retardation (FMR1) gene leading to the absence of the encoded fragile X mental retardation protein 1 (FMRP)." | 1.31 | Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. ( Braun, K; Gruss, M, 2001) |
| "Nomifensine treatment significantly increased TH enzyme amount in substantia nigra (39." | 1.30 | Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra. ( Cano, J; Machado, A; Rodríguez-Gómez, JA; Romero-Ramos, M; Venero, JL, 1997) |
| "Sodium azide is an inhibitor of cytochrome oxidase which produces selective striatal lesions in both rodents and primates." | 1.29 | Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism. ( Beal, MF; Brouillet, E; Henshaw, DR; Hyman, BT; Jenkins, BG; Rosen, BR; Schulz, JB; Sodhi, P, 1994) |
| " These results suggest that SAM rapidly undergoes neurochemical changes which are considered to be part of the normal aging process, and these changes were attenuated by chronic administration of nimodipine." | 1.29 | Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine. ( Kabuto, H; Mori, A; Murakami, M; Sawada, S; Yokoi, I, 1995) |
| " Reducing the ET to 4 degrees C during dosing decreased the peak and average DA levels attained during the 4 x 5 mg/kg METH administration to about 50% of that observed at a 23 degrees C ET." | 1.29 | Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. ( Bowyer, JF; Gough, B; Holson, RR; Lipe, GW; Newport, GD; Slikker, W, 1993) |
| " Eighteen-day-old rats were 35% and 63% more sensitive than adults to the effects of haloperidol on striatal and accumbens turnover and had steeper dose-response curves." | 1.29 | Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol. ( Baldessarini, RJ; Barber, NI; Campbell, A; Gallitano, AL; Gelbard, HA; Marsh, E; Teicher, MH, 1993) |
| " A dose-response effect of apomorphine on extracellular dopamine was observed in all age groups except at 10-11 days of age." | 1.29 | The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on spontaneous release. ( Andersen, SL; Gazzara, RA, 1993) |
| " Part 1 of the study established a dose-response curve and the temporal pattern of GSH loss and recovery in the substantia nigra and striatum following acute BSO treatment." | 1.29 | Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. ( Andersen, JK; Hamill, RW; Harnish, P; Hom, DG; Lee, FY; McNeill, TH; Mo, JQ, 1996) |
| "Biogenic amines in pons and striatum have been dosed in twenty-four months old Wistar male rats." | 1.27 | [Biochemical changes in 24-month-old Wistar rats]. ( Della Zuana, O; Duhault, J; Lonchampt, M; Roman, F; Saint Romas, G, 1984) |
| " Two different dosage schedules of MPTP, i." | 1.27 | Long-term effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine content in young and mature mice. ( Mizuno, Y; Niijima, K; Saitoh, T, 1987) |
| "Haloperidol treatment (2 hours) accelerated striatal DA turnover similarly in all age groups, by about 100%." | 1.26 | Aging and haloperidol-induced dopamine turnover in the nigro-striatal pathway of C57BL/6J mice. ( Finch, CE; Osterburg, HH; Severson, JA, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (18.29) | 18.7374 |
| 1990's | 82 (50.00) | 18.2507 |
| 2000's | 37 (22.56) | 29.6817 |
| 2010's | 15 (9.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Sun, Y | 1 |
| Yang, J | 1 |
| Wu, Y | 1 |
| Yu, J | 1 |
| Li, B | 1 |
| Mora-Gallegos, A | 1 |
| Rojas-Carvajal, M | 1 |
| Salas, S | 1 |
| Saborío-Arce, A | 1 |
| Fornaguera-Trías, J | 1 |
| Brenes, JC | 1 |
| Didriksen, M | 1 |
| Fejgin, K | 1 |
| Nilsson, SR | 1 |
| Birknow, MR | 1 |
| Grayton, HM | 1 |
| Larsen, PH | 1 |
| Lauridsen, JB | 1 |
| Nielsen, V | 1 |
| Celada, P | 1 |
| Santana, N | 1 |
| Kallunki, P | 1 |
| Christensen, KV | 1 |
| Werge, TM | 1 |
| Stensbøl, TB | 1 |
| Egebjerg, J | 1 |
| Gastambide, F | 1 |
| Artigas, F | 1 |
| Bastlund, JF | 1 |
| Nielsen, J | 1 |
| Bergen, MA | 1 |
| Park, HN | 1 |
| Chakraborty, R | 1 |
| Landis, EG | 1 |
| Sidhu, C | 1 |
| He, L | 1 |
| Iuvone, PM | 2 |
| Pardue, MT | 1 |
| Andersen, AD | 1 |
| Blaabjerg, M | 1 |
| Binzer, M | 1 |
| Kamal, A | 1 |
| Thagesen, H | 1 |
| Kjaer, TW | 1 |
| Stenager, E | 1 |
| Gramsbergen, JBP | 1 |
| Minematsu, M | 1 |
| Nakajima, K | 1 |
| Topic, B | 1 |
| Oitzl, MS | 1 |
| Meijer, OC | 1 |
| Huston, JP | 1 |
| de Souza Silva, MA | 1 |
| Ling, Z | 1 |
| Zhu, Y | 1 |
| Tong, CW | 1 |
| Snyder, JA | 1 |
| Lipton, JW | 1 |
| Carvey, PM | 1 |
| Natividad, LA | 1 |
| Tejeda, HA | 1 |
| Torres, OV | 1 |
| O'Dell, LE | 1 |
| Dluzen, DE | 4 |
| Ji, J | 1 |
| McDermott, JL | 4 |
| Heermann, S | 1 |
| Opazo, F | 1 |
| Falkenburger, B | 1 |
| Krieglstein, K | 1 |
| Spittau, B | 1 |
| Li, CR | 1 |
| Huang, GB | 1 |
| Sui, ZY | 1 |
| Han, EH | 1 |
| Chung, YC | 1 |
| Muthian, G | 1 |
| Mackey, V | 1 |
| King, J | 1 |
| Charlton, CG | 1 |
| Oyama, G | 1 |
| Yoshimi, K | 1 |
| Natori, S | 1 |
| Chikaoka, Y | 1 |
| Ren, YR | 1 |
| Funayama, M | 1 |
| Shimo, Y | 1 |
| Takahashi, R | 1 |
| Nakazato, T | 1 |
| Kitazawa, S | 1 |
| Hattori, N | 1 |
| Allen, E | 1 |
| Carlson, KM | 1 |
| Zigmond, MJ | 2 |
| Cavanaugh, JE | 1 |
| Schumm, S | 1 |
| Sebban, C | 1 |
| Cohen-Salmon, C | 2 |
| Callebert, J | 1 |
| Launay, JM | 2 |
| Golmard, JL | 1 |
| Boussicault, L | 1 |
| Petropoulos, I | 1 |
| Hild, A | 1 |
| Rousselet, E | 1 |
| Prigent, A | 1 |
| Friguet, B | 1 |
| Mariani, J | 1 |
| Hirsch, EC | 1 |
| Wu, G | 1 |
| Lu, ZH | 1 |
| Kulkarni, N | 1 |
| Ledeen, RW | 1 |
| Pruett, BS | 1 |
| Salvatore, MF | 1 |
| Miura, H | 1 |
| Qiao, H | 1 |
| Ohta, T | 1 |
| Stanford, JA | 3 |
| Vorontsova, E | 1 |
| Surgener, SP | 1 |
| Gerhardt, GA | 5 |
| Fowler, SC | 1 |
| Purdom, MS | 2 |
| Currier, TD | 1 |
| Dietz, DM | 1 |
| Pletnikov, MV | 1 |
| Alquicer, G | 1 |
| Silva-Gómez, AB | 1 |
| Peralta, F | 1 |
| Flores, G | 1 |
| Pardon, MC | 1 |
| Hanoun, N | 1 |
| Perez-Diaz, F | 1 |
| Joubert, C | 1 |
| Christen, Y | 1 |
| Hamon, M | 1 |
| Saito, S | 1 |
| Takagi, T | 1 |
| Koutoku, T | 1 |
| Saito, ES | 1 |
| Hirakawa, H | 1 |
| Tomonaga, S | 1 |
| Tachibana, T | 1 |
| Denbow, DM | 1 |
| Furuse, M | 1 |
| Segovia, G | 1 |
| Mora, F | 1 |
| Götz, ME | 1 |
| Malz, CR | 1 |
| Dirr, A | 1 |
| Blum, D | 1 |
| Gsell, W | 1 |
| Schmidt, S | 1 |
| Burger, R | 1 |
| Pohli, S | 1 |
| Riederer, P | 1 |
| Boyce, PJ | 1 |
| Finlay, JM | 1 |
| Chanut, E | 1 |
| Labarthe, B | 1 |
| Lacroix, B | 1 |
| Noda, A | 1 |
| Gasdeblay, S | 1 |
| Bondier, JR | 1 |
| Versaux-Botteri, C | 1 |
| Hamaue, N | 1 |
| Ogata, A | 1 |
| Terado, M | 1 |
| Ohno, K | 1 |
| Kikuchi, S | 1 |
| Sasaki, H | 1 |
| Tashiro, K | 1 |
| Hirafuji, M | 1 |
| Minami, M | 1 |
| Villégier, AS | 1 |
| Lotfipour, S | 1 |
| McQuown, SC | 1 |
| Belluzzi, JD | 1 |
| Leslie, FM | 1 |
| Sawada, H | 1 |
| Hishida, R | 1 |
| Hirata, Y | 1 |
| Ono, K | 1 |
| Suzuki, H | 1 |
| Muramatsu, S | 1 |
| Nakano, I | 1 |
| Nagatsu, T | 1 |
| Sawada, M | 1 |
| Roman, F | 1 |
| Della Zuana, O | 1 |
| Lonchampt, M | 1 |
| Saint Romas, G | 1 |
| Duhault, J | 1 |
| Simpkins, JW | 1 |
| Lasley, SM | 1 |
| Greenland, RD | 1 |
| Minnema, DJ | 1 |
| Michaelson, IA | 1 |
| Ponzio, F | 1 |
| Calderini, G | 2 |
| Lomuscio, G | 1 |
| Vantini, G | 1 |
| Toffano, G | 3 |
| Algeri, S | 1 |
| Yoshino, K | 1 |
| Riccardi, F | 1 |
| Covelli, V | 1 |
| Spano, PF | 2 |
| Govoni, S | 2 |
| Trabucchi, M | 3 |
| Montefusco, O | 1 |
| Missale, C | 1 |
| Rozzini, R | 1 |
| Osterburg, HH | 3 |
| Donahue, HG | 1 |
| Severson, JA | 2 |
| Finch, CE | 3 |
| Roth, BL | 1 |
| Galloway, MP | 1 |
| Coscia, CJ | 1 |
| Memo, M | 1 |
| Lucchi, L | 1 |
| Venero, JL | 5 |
| de la Roza, C | 1 |
| Machado, A | 9 |
| Cano, J | 9 |
| Henderson, MG | 1 |
| McMillen, BA | 1 |
| Jinnah, HA | 1 |
| Wojcik, BE | 1 |
| Hunt, M | 1 |
| Narang, N | 1 |
| Lee, KY | 1 |
| Goldstein, M | 1 |
| Wamsley, JK | 1 |
| Langlais, PJ | 1 |
| Friedmann, T | 1 |
| Brouillet, E | 1 |
| Hyman, BT | 1 |
| Jenkins, BG | 1 |
| Henshaw, DR | 1 |
| Schulz, JB | 1 |
| Sodhi, P | 1 |
| Rosen, BR | 1 |
| Beal, MF | 1 |
| Irwin, I | 1 |
| DeLanney, LE | 1 |
| McNeill, T | 1 |
| Chan, P | 1 |
| Forno, LS | 1 |
| Murphy, GM | 1 |
| Di Monte, DA | 1 |
| Sandy, MS | 1 |
| Langston, JW | 1 |
| Gupta, M | 1 |
| Wiener, HL | 1 |
| Kabuto, H | 1 |
| Yokoi, I | 1 |
| Mori, A | 1 |
| Murakami, M | 1 |
| Sawada, S | 1 |
| Armando, I | 1 |
| Nowicki, S | 1 |
| Aguirre, J | 1 |
| Barontini, M | 1 |
| Erdtsieck-Ernste, EB | 1 |
| Feenstra, MG | 1 |
| Botterblom, M | 1 |
| Boer, GJ | 1 |
| Ali, SF | 6 |
| Holson, RR | 2 |
| Newport, GD | 3 |
| Slikker, W | 3 |
| Bowyer, JF | 2 |
| Gilad, GM | 1 |
| Li, R | 1 |
| Wyatt, RJ | 1 |
| Tizabi, Y | 1 |
| Santiago, M | 4 |
| Crawford, CA | 1 |
| McDougall, SA | 1 |
| Bardo, MT | 1 |
| David, SN | 1 |
| Cadet, JL | 1 |
| Navarro, M | 1 |
| Rodríguez de Fonseca, F | 1 |
| Hernández, ML | 2 |
| Ramos, JA | 3 |
| Fernández-Ruiz, JJ | 2 |
| Tsai, YF | 1 |
| Tsai, HW | 1 |
| Tai, MY | 1 |
| Budygin, EA | 1 |
| Kovalev, GI | 1 |
| Gaĭntdinov, RR | 1 |
| Kudrin, VS | 2 |
| Voronina, TA | 1 |
| Stewart, J | 1 |
| Rajabi, H | 1 |
| Gough, B | 1 |
| Lipe, GW | 1 |
| Tsuchida, K | 1 |
| Ujike, H | 1 |
| Kanzaki, A | 1 |
| Fujiwara, Y | 1 |
| Akiyama, K | 1 |
| Joseph, SA | 1 |
| Walker, DW | 1 |
| Gazzara, RA | 2 |
| Andersen, SL | 2 |
| Teicher, MH | 1 |
| Barber, NI | 1 |
| Gelbard, HA | 1 |
| Gallitano, AL | 1 |
| Campbell, A | 1 |
| Marsh, E | 1 |
| Baldessarini, RJ | 1 |
| Desole, MS | 1 |
| Esposito, G | 1 |
| Enrico, P | 1 |
| Miele, M | 1 |
| Fresu, L | 1 |
| De Natale, G | 1 |
| Miele, E | 1 |
| Grella, G | 1 |
| Afonso, D | 2 |
| Santana, C | 2 |
| Rodriguez, M | 2 |
| Yao, H | 1 |
| Nagao, T | 1 |
| Ooboshi, H | 1 |
| Matsumoto, T | 1 |
| Hirano, M | 1 |
| Nakahara, T | 1 |
| Sadoshima, S | 1 |
| Uchimura, H | 1 |
| Fujishima, M | 1 |
| Rose, S | 2 |
| Nomoto, M | 1 |
| Jackson, EA | 1 |
| Gibb, WR | 1 |
| Jaehnig, P | 1 |
| Jenner, P | 2 |
| Marsden, CD | 2 |
| Jensen, EW | 1 |
| Eldrup, E | 2 |
| Kelbaek, H | 1 |
| Nielsen, SL | 1 |
| Christensen, NJ | 2 |
| Cabib, S | 1 |
| Puglisi-Allegra, S | 1 |
| D'Amato, FR | 1 |
| Hastings, JA | 3 |
| Pavia, JM | 2 |
| Morris, MJ | 3 |
| Woods, JM | 1 |
| Druse, MJ | 1 |
| Nakano, M | 1 |
| Mizuno, T | 1 |
| Andersen, JK | 1 |
| Mo, JQ | 1 |
| Hom, DG | 1 |
| Lee, FY | 1 |
| Harnish, P | 1 |
| Hamill, RW | 1 |
| McNeill, TH | 1 |
| Ueda, Y | 1 |
| Komatsu, M | 1 |
| Hiramatsu, M | 1 |
| Cransac, H | 1 |
| Peyrin, L | 2 |
| Cottet-Emard, JM | 1 |
| Farhat, F | 1 |
| Pequignot, JM | 1 |
| Reber, A | 1 |
| Bonnin, A | 1 |
| de Miguel, R | 2 |
| Castro, JG | 1 |
| Penit-Soria, J | 1 |
| Durand, C | 1 |
| Herve, D | 1 |
| Besson, MJ | 1 |
| Schneider, JS | 2 |
| Romero-Ramos, M | 1 |
| Rodríguez-Gómez, JA | 1 |
| Sajnani, GG | 1 |
| Abreu, P | 1 |
| Castro, R | 1 |
| Muneoka, K | 1 |
| Mikuni, M | 1 |
| Ogawa, T | 1 |
| Kitera, K | 1 |
| Kamei, K | 1 |
| Takigawa, M | 1 |
| Takahashi, K | 1 |
| McClure-Sharp, JM | 1 |
| Hebert, MA | 1 |
| Philpot, RM | 2 |
| Kirstein, CL | 2 |
| Schneider, ML | 1 |
| Clarke, AS | 1 |
| Kraemer, GW | 2 |
| Roughton, EC | 1 |
| Lubach, GR | 1 |
| Rimm-Kaufman, S | 1 |
| Schmidt, D | 1 |
| Ebert, M | 1 |
| Míguez, JM | 1 |
| Recio, J | 1 |
| Sánchez-Barceló, E | 1 |
| Aldegunde, M | 1 |
| Lemierre, S | 1 |
| Rouch, C | 1 |
| Nicolaidis, S | 1 |
| Orosco, M | 1 |
| Maloney, RE | 1 |
| Dawson, R | 1 |
| Pelleymounter, MA | 1 |
| Cullen, MJ | 1 |
| Gollub, M | 1 |
| Liu, S | 1 |
| Kucherianu, VG | 1 |
| Kryzhanovskiĭ, GN | 1 |
| Iurasov, VV | 1 |
| Nikushkin, EV | 1 |
| Zhigal'tsev, IV | 1 |
| Goettl, VM | 1 |
| Wemlinger, TA | 1 |
| Duchemin, AM | 1 |
| Neff, NH | 1 |
| Hadjiconstantinou, M | 1 |
| Vieira-Coelho, MA | 1 |
| Hussain, T | 1 |
| Kansra, V | 1 |
| Serrao, MP | 1 |
| Guimaraes, JT | 1 |
| Pestana, M | 2 |
| Soares-Da-Silva, P | 4 |
| Lokhandwala, MF | 1 |
| Ueda, S | 1 |
| Aikawa, M | 1 |
| Ishizuya-Oka, A | 1 |
| Yamaoka, S | 1 |
| Koibuchi, N | 1 |
| Yoshimoto, K | 1 |
| Shui, H | 1 |
| Peng, Y | 1 |
| Wu, R | 1 |
| Tsai, Y | 1 |
| Miller, DB | 1 |
| O'Callaghan, JP | 1 |
| Mandavilli, BS | 1 |
| Van Houten, B | 1 |
| MohanKumar, PS | 1 |
| MohanKumar, SM | 1 |
| Quadri, SK | 1 |
| Voogt, JL | 1 |
| Lee, JJ | 1 |
| Chang, CK | 1 |
| Liu, IM | 1 |
| Chi, TC | 1 |
| Yu, HJ | 1 |
| Cheng, JT | 1 |
| Laviola, G | 1 |
| Pascucci, T | 1 |
| Pieretti, S | 1 |
| Fox, CM | 1 |
| Gash, DM | 1 |
| Smoot, MK | 1 |
| Cass, WA | 1 |
| Bairam, A | 1 |
| Néji, H | 1 |
| Kinkead, R | 1 |
| Marchal, F | 1 |
| Campbell, BM | 1 |
| Gresch, PJ | 1 |
| Walker, PD | 1 |
| Ferreira, A | 1 |
| Bettencourt, P | 1 |
| Correia, F | 1 |
| Serrão, P | 1 |
| Martins, L | 1 |
| Cerqueira-Gomes, M | 1 |
| Imam, SZ | 1 |
| Elsworth, JD | 1 |
| Morrow, BA | 1 |
| Roth, RH | 1 |
| Vicente-Torres, MA | 2 |
| Muñoz, E | 2 |
| Dávila, D | 2 |
| Gil-Loyzaga, P | 2 |
| Gruss, M | 1 |
| Braun, K | 1 |
| Meyer, JS | 1 |
| Summavielle, T | 1 |
| Magalhães, A | 1 |
| Castro-Vale, I | 1 |
| de Sousa, L | 1 |
| Tavares, MA | 1 |
| Muskiet, FA | 1 |
| Fremouw-Ottevangers, DC | 1 |
| van der Meulen, J | 1 |
| Wolthers, BG | 1 |
| de Vries, JA | 1 |
| Dalmaz, Y | 1 |
| Sann, L | 1 |
| Dutruge, J | 1 |
| Davis, AJ | 1 |
| Holzbauer, M | 1 |
| Sharman, DF | 1 |
| Fernandes, MH | 2 |
| Fernandez-Ruiz, J | 1 |
| Cebeira, M | 1 |
| Pasinetti, GM | 1 |
| Kelly, AB | 1 |
| Kohama, S | 1 |
| Morgan, DG | 1 |
| Reinhard, JF | 1 |
| Stellwagen, RH | 1 |
| Arevalo, R | 1 |
| Darney, KJ | 1 |
| Goldman, JM | 1 |
| Vandenbergh, JG | 1 |
| Martineau, J | 1 |
| Garreau, B | 1 |
| Barthélémy, C | 1 |
| Jouve, J | 1 |
| Lelord, G | 1 |
| Hadfield, MG | 1 |
| Milio, C | 1 |
| Castañeda, E | 1 |
| Whishaw, IQ | 1 |
| Lermer, L | 1 |
| Robinson, TE | 1 |
| Taylor, MD | 1 |
| de Ceballos, ML | 1 |
| Chong, PN | 1 |
| Tatton, WG | 1 |
| Greenwood, CE | 1 |
| Salo, PT | 1 |
| Seniuk, NA | 1 |
| Dluzen, D | 1 |
| McDermott, J | 1 |
| Sato, N | 1 |
| Shimizu, H | 1 |
| Shimomura, Y | 1 |
| Uehara, Y | 1 |
| Takahashi, M | 1 |
| Negishi, M | 1 |
| Yeung, JM | 1 |
| Friedman, E | 1 |
| Hetland, ML | 1 |
| Bratholm, P | 1 |
| Date, I | 1 |
| Felten, DL | 1 |
| Felten, SY | 1 |
| Giorgi, O | 2 |
| Porceddu, ML | 2 |
| Pepitoni, S | 1 |
| Serra, GP | 1 |
| Biggio, G | 2 |
| Walters, DE | 1 |
| Chapman, CD | 1 |
| Howard, SG | 1 |
| Buu, NT | 1 |
| Debinski, W | 1 |
| Fornstedt, B | 1 |
| Pileblad, E | 1 |
| Carlsson, A | 1 |
| Moretti, A | 2 |
| Carfagna, N | 2 |
| Trunzo, F | 2 |
| Bruno, JP | 1 |
| Jackson, D | 1 |
| Stricker, EM | 1 |
| Reinoso-Suárez, F | 1 |
| McKeon, TW | 1 |
| Hendley, ED | 1 |
| Vaughn, DM | 1 |
| Smyth, GB | 1 |
| Whitmer, WL | 1 |
| Satjawatcharaphong, C | 1 |
| Ebert, MH | 1 |
| Schmidt, DE | 1 |
| McKinney, WT | 1 |
| Tigges, M | 1 |
| Fernandes, A | 1 |
| Tigges, J | 1 |
| Lun, A | 1 |
| Szuecz, L | 1 |
| Gross, J | 1 |
| Horvath, G | 1 |
| Nagy, I | 1 |
| De Montis, G | 1 |
| Mele, S | 1 |
| MacRae, PG | 1 |
| Spirduso, WW | 1 |
| Walters, TJ | 1 |
| Farrar, RP | 1 |
| Wilcox, RE | 1 |
| Roizen, MF | 1 |
| Koblin, DD | 1 |
| Johnson, BH | 1 |
| Eger, EI | 1 |
| Bainton, CR | 1 |
| Lurz, FW | 1 |
| Saitoh, T | 1 |
| Niijima, K | 1 |
| Mizuno, Y | 1 |
| Cousin, KM | 1 |
| Gerald, MC | 1 |
| Uretsky, NJ | 1 |
164 other studies available for 3,4-dihydroxyphenylacetic acid and Aging
| Article | Year |
|---|---|
Age-dependent dopaminergic dysfunction following fetal exposure to atrazine in SD rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Atrazine; Corpus Striatum; Dopamine; Dopamine Plasma | 2014 |
Age-dependent effects of environmental enrichment on spatial memory and neurochemistry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Environment; gamma-Aminobutyric Acid; Glut | 2015 |
Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Auditory Perception; Corpus Striatum; DiGeorge Syndr | 2017 |
Altered Refractive Development in Mice With Reduced Levels of Retinal Dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biomarkers; Disease Models, Animal; Disease Progress | 2016 |
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aging; Antiparkinson Agents; Catecholamines; Dopamine; | 2017 |
Significant effect of dimethylsulfoniopropionate on Parkinson's disease of senescence-accelerated mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Alzheimer Disea | 2008 |
Differential susceptibility to extinction-induced despair and age-dependent alterations in the hypothalamic-pituitary-adrenal axis and neurochemical parameters.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Biomarkers; Depression; Dopamine; | 2008 |
Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Analysis of Variance; Animals; Body Weight; Brai | 2009 |
Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Bicuculline; Dopamine; Extracellular Space; GABA Ant | 2010 |
Age-related changes in nigrostriatal dopaminergic function in heterozygous mutant dopamine transporter knock-out mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Dopamine Plasma Membrane | 2010 |
Aged Tgfbeta2/Gdnf double-heterozygous mice show no morphological and functional alterations in the nigrostriatal system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Chromatography, High Pressure | 2010 |
Effects of 6-hydroxydopamine lesioning of the medial prefrontal cortex on social interactions in adolescent and adult rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Exploratory Behavior; Interpersonal Relati | 2010 |
Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Birth | 2010 |
Impaired in vivo dopamine release in parkin knockout mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Body Weight; Corpus Striatum; Dopamine; Homovanillic | 2010 |
L-DOPA reverses motor deficits associated with normal aging in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Brain Chemistry; Dopamine; Dopamine Agents; H | 2011 |
Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; An | 2012 |
Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Aging; Animals; Antiparkinson Agents; Blott | 2012 |
Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Glial Cell Line-Derived Neurotrophic Facto | 2013 |
Influence of aging and social isolation on changes in brain monoamine turnover and biosynthesis of rats elicited by novelty stress.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Brain; Chromatography, High Pre | 2002 |
Aged Fischer 344 rats exhibit altered locomotion in the absence of decreased locomotor activity: exacerbation by nomifensine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Analysis of Variance; Animals; Corpus Striatum; | 2002 |
Microdialysis studies of D-amphetamine-evoked striatal dopamine overflow in young versus aged F344 rats: effects of concentration and order of administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Central Nervous System Stimulants; Chromatography, H | 2003 |
Differential effects of post-implantation time on potassium- versus D-amphetamine-evoked dopamine overflow in the striatum of F344 rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dextroamphetamine; Dopamine; Extracellular Space; Mi | 2003 |
Postnatal weight gain inhibition does not account for neurobehavioral consequences of neonatal Borna disease virus infection.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Animals, Newborn; Behavior, An | 2003 |
Neonatal ventral hippocampus lesion alters the dopamine content in the limbic regions in postpubertal rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Behavior, Animal; Denervation; Dis | 2004 |
Long-term treatment with the antioxidant drug EGb 761 at senescence restored some neurobehavioral effects of chronic ultramild stress exposure seen in young mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Behavior, Animal; Brain; Brain Chemist | 2004 |
Differences in catecholamine metabolism and behaviour in neonatal broiler and layer chicks.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Body Weight; Brain; Catecholamines; Chickens; Dopami | 2004 |
Dopamine and GABA increases produced by activation of glutamate receptors in the nucleus accumbens are decreased during aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Ana | 2005 |
Brain aging phenomena in migrating sockeye salmon Oncorhynchus nerka nerka.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animal Migration; Animals; Antioxidants; Apoptosis; Brain; Ca | 2005 |
Neonatal depletion of cortical dopamine: effects on dopamine turnover and motor behavior in juvenile and adult rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Aging; Analysis of Variance; Animals; Animals, Ne | 2005 |
Variations of dopamine, serotonin, and amino acid concentrations in Noda epileptic rat (NER) retina.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acids; Animals; Animals, Newborn; Biogenic Monoamines; | 2006 |
Brain catecholamine alterations and pathological features with aging in Parkinson disease model rat induced by Japanese encephalitis virus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Brain Chemistry; Catecholamines; Dopamine; En | 2006 |
Tranylcypromine enhancement of nicotine self-administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Benzazepines; Chromatography, High Pressure Liquid; | 2007 |
Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animal | 2007 |
Aging and sex differences in striatal dopaminergic function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amphetamine; Animals; Dopamine; Dopamine Uptake Inhibitors; F | 2007 |
[Biochemical changes in 24-month-old Wistar rats].
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholinesterase; Aging; Animals; Choline; Choline O-Acetyltrans | 1984 |
Regional changes in monoamine metabolism in the aging constant estrous rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Corpus Striatum; Dopamine; Estrus; Female; Ho | 1984 |
Influence of chronic inorganic lead exposure on regional dopamine and 5-hydroxytryptamine turnover in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Dopamine; Erythrocytes; Female; Homovanillic | 1984 |
Changes in monoamines and their metabolite levels in some brain regions of aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Dopamine; Homovanillic Acid; Hydroxyindoleace | 1982 |
[Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Aged; Aging; Biogenic Amines; Chromatography, Hig | 1982 |
Rat dopaminergic function in the retina during aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Binding Sites; Corpus Striatum; Enkephalins; Male; P | 1981 |
Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as drug for the elderly.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Male; Propanolamines; Rats; Rats, Inbred Stra | 1983 |
Catecholamine levels and turnover during aging in brain regions of male C57BL/6J mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Catecholamines; Dopamine; Epinephrine; Mice; | 1981 |
Aging and haloperidol-induced dopamine turnover in the nigro-striatal pathway of C57BL/6J mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Haloperidol; Male; Methyl | 1981 |
The effects of morphine on catecholamine metabolism during postnatal development.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Medulla; Aging; Animals; Catecholamines; Corpus Striatum; Do | 1980 |
Aging process affects a single class of dopamine receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Aging; Animals; Corpus Striatum; Haloperidol; Hum | 1980 |
Age-related changes on monoamine turnover in hippocampus of rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Hippocampus; Hydroxyindoleacetic Acid; Imm | 1993 |
Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amitriptyline; Amygdala; Analysis of Variance; Animals; Brain | 1993 |
Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Caudate Nucleus; Disease Models, Animal; Dopa | 1994 |
Effect of ageing on monoamine turnover in the prefrontal cortex of rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Dopamine; Homovanillic Acid; Hy | 1993 |
Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Aging; Animals; Azides; Biogenic Amines; Cor | 1994 |
Aging and the nigrostriatal dopamine system: a non-human primate study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analys | 1994 |
Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; | 1995 |
Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Administration, Oral; Aging; Animals; Brain; Calcium | 1995 |
A decreased tubular uptake of dopa results in defective renal dopamine production in aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Aromatic-L-Amino-Acid Decarboxylases; Biological Tra | 1995 |
Postnatal exposure to the beta-adrenoceptor agonist clenbuterol has regionally selective direct and long-term effects on rat brain beta-adrenoceptors and monoamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Brain; Cerebellum; Clenbuterol; Do | 1993 |
Development of dopamine and N-methyl-D-aspartate systems in rat brain: the effect of prenatal phencyclidine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Corpus Striatum; Dopamine; Female; | 1993 |
Effects of genotype on age-related alterations in the concentrations of stress hormones in plasma and hypothalamic monoamines in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenocorticotropic Hormone; Aging; Animals; Biogenic Monoamines; Co | 1993 |
Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dialys | 1993 |
Effects of EEDQ on the synthesis and metabolism of dopamine in preweanling and adult rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Suckling; Dihydroxyphenylalanine; Dopamine; | 1994 |
MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbre | 1994 |
Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Cannabinoids; Cannabis; Corpus Str | 1994 |
Comparison of brain dopamine depletion induced by low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in young and aged rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; | 1994 |
[Age-related changes in the dopaminergic system in rat striatum].
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Basal Metabolism; Corpus Striatum; Dopamine; Homovan | 1993 |
Estradiol derived from testosterone in prenatal life affects the development of catecholamine systems in the frontal cortex in the male rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Aromatase Inhibitors; Catecholamin | 1994 |
Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Caudate Nucleus; Chromatography | 1993 |
Ontogeny of enhanced striatal dopamine release in rats with methamphetamine-induced behavioral sensitization.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Brain Chemistry; Chromatography, H | 1994 |
Monoamine concentrations in cerebrospinal fluid of fetal and newborn sheep.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Biogenic Monoamines; Dinoprostone; | 1994 |
Calcium dependency and tetrodotoxin sensitivity of neostriatal dopamine release in 5-day-old and adult rats as measured by in vivo microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Calcium; Dopamine; Kinetics; Micro | 1994 |
Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Dose-Response Relationshi | 1993 |
The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on spontaneous release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Apomorphine; Corpus Striatum; Dopamine; Dose-Respons | 1993 |
Effects of ageing on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxic effects on striatum and brainstem in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Ascorbic Acid; Brain Stem; Corpus Stri | 1993 |
Neonatal lateralization of behavior and brain dopaminergic asymmetry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Dopamine; Female; Functional Later | 1993 |
Ischemia-induced changes in brain monoamine metabolism in aged spontaneously hypertensive rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Brain; Corpus Striatum; Dopamin | 1993 |
Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Brain Chemistry; Callithrix; Chromatography, | 1993 |
Venous plasma noradrenaline increases with age: correlation to total blood volume and long-term smoking habits.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Aging; Benserazide; Blood Volume; Bo | 1993 |
Effects of postnatal stress on dopamine mesolimbic system responses to aversive experiences in adult life.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Apomorphine; Dopamine; Female; | 1993 |
Effects of estrogen upon dopamine release from the corpus striatum of young and aged female rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amphetamine; Animals; Corpus Striatum; Dopamine; Estrogens; F | 1993 |
Altered in vivo catecholamine release in the hypothalamic paraventricular nucleus of the aged rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Catecholamines; Homovanillic Acid; Male; Norepinephr | 1996 |
Effects of chronic ethanol consumption and aging on dopamine, serotonin, and metabolites.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Alcohol Drinking; Animals; Brain; Dopamine; Hydroxyindoleacet | 1996 |
Age-related changes in the metabolism of neurotransmitters in rat striatum: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Male; Microdialysis; Mono | 1996 |
Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Buthionine Sulfoximine; Corpus Striatu | 1996 |
Free radical scavenging activity of the Japanese herbal medicine toki-shakuyaku-san (TJ-23) and its effect on superoxide dismutase activity, lipid peroxides, glutamate, and monoamine metabolites in aged rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acids; Animals; Bepridil; Biogenic Monoamines; Biphenyl | 1996 |
Age-related changes in monoamines within the olfactory bulbs of the Fischer 344 male rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Dopamine; Male; Olfactory Bulb; | 1996 |
Aging effects on monoamines in rat medial vestibular and cochlear nuclei.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Anterior Hypothalamic Nucleus; Auditory Threshold; C | 1996 |
Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Brain; Dronabinol; Female; Gene Ex | 1996 |
Morphological and biochemical adaptations to unilateral dopamine denervation of the neostriatum in newborn rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Basal Ganglia; Denervation; Dopami | 1997 |
Neuropeptide Y and [Leu31,Pro34]neuropeptide Y potentiate potassium-induced noradrenaline release in the paraventricular nucleus of the aged rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Cerebral Ventricles; Drug Synergism; Homovanillic Ac | 1997 |
Preservation of autoreceptor-mediated increases in dopamine synthesis in aged mice with experimentally-induced parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Aromat | 1997 |
Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Blotting, Western; Dopamine; Dopamine Uptake Inhibit | 1997 |
Pre/postnatal dopamine D1 receptor stimulation induces a differential reduction of serotonin levels in hippocampus and superior colliculus of puber rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Aging; A | 1997 |
Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Cortex; Aging; Analysis of Variance; Animals; Biogenic Monoa | 1997 |
In vitro studies of endogenous noradrenaline and NPY overflow from the rat hypothalamus during maturation and ageing.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Animals; Calcium; Chromatography, High Pressure | 1998 |
Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Aging; Animals; Brain Chemistry; Chrom | 1998 |
The effects of repeated alcohol exposure on the neurochemistry of the periadolescent nucleus accumbens septi.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Alcoholism; Animals; Dopamine; Dose-Response Relationship, Dr | 1998 |
Prenatal stress alters brain biogenic amine levels in primates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Biogenic Amines; Brain; Female; Ho | 1998 |
Changes with age in daytime and nighttime contents of melatonin, indoleamines, and catecholamines in the pineal gland: a comparative study in rat and Syrian hamster.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Aging; Animals; Catecholamines; Circadian Rhyth | 1998 |
Combined effect of obesity and aging on feeding-induced monoamine release in the rostromedial hypothalamus of the Zucker rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Dopamine; Eating; Food; Hydroxy | 1998 |
Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Corpus Striatum; Dextroampheta | 1999 |
Repeated cocaine exposure: effects on catecholamines in the nucleus accumbens septi of periadolescent animals.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Catecholamines; Cocaine; Dopamine; Dopamine Uptake I | 1999 |
An age-related decline in striatal taurine is correlated with a loss of dopaminergic markers.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biomarkers; Brain-Derived Neurotrophic Factor; Corpu | 1999 |
[Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Administration, Intran | 1999 |
GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; G(M1) Ganglioside; Male; | 1999 |
Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Aromatic-L-Amino-Acid Decarbox | 1999 |
Age-related dopamine deficiency in the mesostriatal dopamine system of zitter mutant rats: regional fiber vulnerability in the striatum and the olfactory tubercle.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antibodies; Disease Models, Animal; Dopamine; Free R | 2000 |
Evaluation of L-DOPA biotransformation during repeated L-DOPA infusion into the striatum in freely-moving young and old rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antiparkinson Agents; Chromatography, High Pressure | 2000 |
Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Area Under Curve; Body Temperature; Central Nervous | 2000 |
DNA damage in brain mitochondria caused by aging and MPTP treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Animals; Brain Chemistry; DNA Damage; DNA, Mitoc | 2000 |
Effects of chronic bromocriptine treatment on tyrosine hydroxylase (TH) mRNA expression, TH activity and median eminence dopamine concentrations in ageing rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Arcuate Nucleus of Hypothalamus; Bromocriptine; Dopa | 2001 |
Changes in endogenous monoamines in aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Catechol O-Methyltransferase; C | 2001 |
Striatal dopamine sensitization to D-amphetamine in periadolescent but not in adult rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Caud | 2001 |
Neuroprotective effects of GDNF against 6-OHDA in young and aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Cell Survival; Dopamine; Glial Cell Line-Derived Neu | 2001 |
Carbachol effect on carotid body dopamine in vitro release in response to hypoxia in adult and pup rabbit.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Carbachol; Carotid Body; Cholinergic Agonists; Dopam | 2001 |
Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Dopamine; Dopamine Agonists; Dopam | 2001 |
Heart failure, aging, and renal synthesis of dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Age Factors; Aged; Aging; Aldosterone; Cardiac Output, Low; C | 2001 |
Aging increases the susceptiblity to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain Chemistry; Central Nervous System Stimulants; | 2001 |
Prenatal cocaine exposure increases mesoprefrontal dopamine neuron responsivity to mild stress.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Cocaine; Cocaine-Related Disorders; Dopamine; Electr | 2001 |
Changes in the cochlear dopaminergic system of the aged rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Chromatography, High Pressure Liquid; Cochlea; Dopam | 2001 |
Effects of aging on cochlear monoamine turnover.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Chromatography, High Pressure L | 2002 |
Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Alanine; Amino Acids; Animals; Aspartic Acid; Brain; Brain St | 2001 |
Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Apoptosis; Brain; Dopamine; Female; Homovanillic Aci | 2002 |
Neonatal exposure to cocaine: altered dopamine levels in the amygdala and behavioral outcomes in the developing rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amygdala; Animals; Animals, Newborn; Cocaine; Dopamine; Femal | 2002 |
Determination of some L-3,4-dihydroxyphenylalanine and dopamine metabolites in urine by means of mass fragmentography.
Topics: 3-Methoxy-4-hydroxyphenylethanol; 3,4-Dihydroxyphenylacetic Acid; Adult; Aging; Child; Child, Presch | 1978 |
Age-related changes in catecholamine metabolites of human urine from birth to adulthood.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Aging; Catecholamines; Child; Child, Preschool; D | 1979 |
Postnatal development of dopamine deamination in the striatum of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Deamination; Dopamine; Female; Homo | 1975 |
Effect of alpha-human atrial natriuretic peptide on the synthesis of dopamine in the rat kidney.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3',5'-Cyclic-GMP Phosphodiesterases; Aging; Animals; Atrial Natriure | 1992 |
Comparisons between brain dopaminergic neurons of juvenile and aged rats: sex-related differences.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Dopamine; Female; Male; Neurons; Rats; Rats, | 1992 |
Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acid Sequence; Animals; Biogenic Monoamines; Corpus Str | 1992 |
Dopaminergic neuron development in rats: biochemical study from prenatal life to adulthood.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Female; Hydroxyindoleacetic Acid; Mesencep | 1992 |
Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus | 1992 |
Neuroendocrine responses to social regulation of puberty in the female house mouse.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Estradiol; Female; Hypothalamus; Hypothala | 1992 |
[Development in the metabolism of dopamine and its derivatives. Application to gross development disorders].
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Autistic Disorder; Child; Child, Presch | 1992 |
Regional brain monoamine levels and utilization in middle-aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Brain; Dopamine; Hydroxyindolea | 1990 |
Dopamine depletion in neonatal rats: effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Behavior, Animal; Corpus Striatum; | 1990 |
Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Hydraz | 1991 |
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Basal | 1991 |
Transmitter synthesis increases in substantia nigra neurons of the aged mouse.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Axonal Transport; Corpus Striatum; Dihydroxyphenylal | 1991 |
Age effects on monoamine turnover of the rat substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Aging; Animals; Aromatic Amino Acid Decarboxyla | 1991 |
Striatal dopamine release in vitro from immature male rats shows enhanced responsiveness to pulsatile, but not continuous, infusions of L-dopa.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Levodopa; Male; Pulsatile | 1991 |
A study on the renal synthesis of dopamine in aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Chromatography, High Pressure Liquid; Dopamine; Kidn | 1991 |
Sucrose feeding at weaning alters the preference for sucrose in adolescence.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Chromatography, High Pressure Liquid; Dopamine; Drin | 1991 |
Effect of aging and diet restriction on monoamines and amino acids in cerebral cortex of Fischer-344 rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acids; Animals; Biogenic Monoamines; Cerebral Cortex; C | 1991 |
The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Catecholamine | 1991 |
The effect of long-term treatment with deprenyl on basal and L-dopa evoked dopamine release in vitro from the corpus striatum of aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amphetamine; Animals; Corpus Striatum; Dopamine; In Vitro Tec | 1991 |
Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; | 1990 |
Differential effect of aging on 3H-SCH 23390 binding sites in the retina and in distinct areas of the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Benzazepines; Brain Chemistry; Cerebral Cortex; Corp | 1990 |
Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dialysis; Dopamine; Female; Haloper | 1990 |
Vesicular and ganglionic norepinephrine in the rat: progressive increase with age.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Catecholamines; Chromatography, High Pressure | 1990 |
In vivo autoxidation of dopamine in guinea pig striatum increases with age.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Cerebral Cortex; Corpus Striatum; Cysteinyldo | 1990 |
Effect of aging on monoamines and their metabolites in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Brain Chemistry; Dopamine; Homovanillic Acid; | 1987 |
Effect of dopamine-depleting brain lesions in rat pups: role of striatal serotonergic neurons in behavior.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Behavior, Animal; Brain; Corpus St | 1987 |
Changes in biogenic amines in rat hippocampus during development and aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Aging; Animals; Dopamine; Hippocampus; Homovani | 1988 |
Brain monoamines and metabolites in hypertensive and hyperactive rat strains.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Brain Chemistry; Dopamine; Fema | 1988 |
Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Cisterna Magna; Female; Homovan | 1989 |
A longitudinal study of the effect of different social rearing conditions on cerebrospinal fluid norepinephrine and biogenic amine metabolites in rhesus monkeys.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Amines; Female; Homovanillic Acid; Hydroxyi | 1989 |
Dopamine synthesis and metabolism in rhesus monkey retina: development, aging, and the effects of monocular visual deprivation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Dopamine; Macaca mulatta; Osmolar | 1989 |
Age-related changes of catecholamines and their metabolites content in the visual system of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Catecholamines; Dopamine; Geniculate Bodies; Homovan | 1989 |
Effect of mild postnatal hypoxia and L-dopa administration on dopamine concentration in striata of the newborn rat and long term sequelae on dopamine turnover.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Corpus Striatum; Dopamine; Hypoxia | 1989 |
Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Aging; Animals; Benzazepines; Binding Sites; Corp | 1987 |
Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolites in presenescent older rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Kineti | 1987 |
Mechanism of age-related and nitrous oxide-associated anesthetic sensitivity: the role of brain catecholamines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain Chemistry; Dopamine; Drug Resistance; Male; Mi | 1988 |
Long-term effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine content in young and mature mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus | 1987 |
The change with age in biogenic amines and their metabolites in the striatum of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Animals; Biogenic Amines; Corpus Striatum; Dopam | 1986 |
Effect of nialamide on the metabolism of dopamine injected into the nucleus accumbens of old rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Dopamine; Homovanillic Acid; Limbic System; Male; Mo | 1986 |
Brain catecholamine content and turnover in aging rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; alpha-Methyltyrosine; Animals; Brain; Catecholamines; Corpus | 1985 |